Overview

Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology

Status:
Unknown status
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
Enalapril would significantly reduce progression of renal disease in patients with Chronic Kidney Disease of Uncertain aetiology.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ministry of Health, Sri Lanka
Collaborator:
World Health Organization
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Calcium
Calcium, Dietary
Enalapril
Enalaprilat
Enzyme Inhibitors